Published in PLoS One on January 30, 2013
Genomic Classification of Cutaneous Melanoma. Cell (2015) 3.91
DNA methylation characteristics of primary melanomas with distinct biological behaviour. PLoS One (2014) 0.84
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma. Pigment Cell Melanoma Res (2014) 0.83
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell Melanoma Res (2014) 0.81
Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions. Cancer Res (2014) 0.80
Identification of metastasis-associated genes in colorectal cancer through an integrated genomic and transcriptomic analysis. Chin J Cancer Res (2013) 0.80
Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges. Front Genet (2016) 0.78
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma. Oncoimmunology (2017) 0.75
Aberrant expression of kallikrein-related peptidase 7 is correlated to human melanoma aggressiveness by stimulating cell migration and invasion. Mol Oncol (2017) 0.75
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
L1 penalized estimation in the Cox proportional hazards model. Biom J (2010) 4.02
Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst (2006) 3.17
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics (2008) 3.11
The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A (2005) 3.05
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res (2007) 2.62
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res (2007) 2.51
Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell (2001) 2.45
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res (2007) 2.11
Integrative genome comparison of primary and metastatic melanomas. PLoS One (2010) 1.97
Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One (2010) 1.84
High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene (2007) 1.83
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene (2007) 1.72
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol Ther (2005) 1.63
Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Ann Surg Oncol (2010) 1.59
Melanoma genetics and the development of rational therapeutics. J Clin Invest (2005) 1.50
CGHregions: dimension reduction for array CGH data with minimal information loss. Cancer Inform (2007) 1.49
Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res (2010) 1.47
Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma. Ann Surg (2012) 1.46
Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res (2009) 1.40
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res (2009) 1.36
A gene expression signature of invasive potential in metastatic melanoma cells. PLoS One (2009) 1.21
Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt. Pigment Cell Melanoma Res (2009) 1.19
Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol (2011) 1.15
Promoter methylation profiling of 30 genes in human malignant melanoma. Cancer Sci (2004) 1.13
A gene expression signature associated with survival in metastatic melanoma. J Transl Med (2006) 1.13
Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? Clin Exp Metastasis (2010) 1.11
Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma. PLoS One (2011) 1.09
Epigenetics in human melanoma. Cancer Control (2009) 1.09
DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res (2011) 1.08
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Res (2011) 1.06
Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer (2011) 1.06
Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted. PLoS One (2010) 1.05
Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study. Genes Chromosomes Cancer (2010) 1.04
Aberrant DNA methylation in malignant melanoma. Melanoma Res (2010) 1.04
Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects. Histopathology (2010) 1.01
Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma. Genes Chromosomes Cancer (2010) 1.00
Ezrin in primary cutaneous melanoma. Mod Pathol (2005) 0.99
Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer (2010) 0.99
Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion. Br J Cancer (2010) 0.97
Melanomagenesis: overcoming the barrier of melanocyte senescence. Cell Cycle (2008) 0.97
Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity? Curr Opin Oncol (2012) 0.96
Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Mod Pathol (2009) 0.96
Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol (2009) 0.95
EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int J Cancer (2007) 0.92
Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet Cytogenet (2008) 0.89
Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma. Cancer Res (2010) 0.89
A sparse regulatory network of copy-number driven gene expression reveals putative breast cancer oncogenes. IEEE/ACM Trans Comput Biol Bioinform (2012) 0.87
Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am (2009) 0.87
Melanoma staging: facts and controversies. Clin Dermatol (2010) 0.86
Genomic analyses identify gene candidates for acquired irinotecan resistance in melanoma cells. Int J Oncol (2008) 0.86
Adolescent melanoma: risk factors and long term survival. Eur J Surg Oncol (2006) 0.85
Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma. Ann Surg Oncol (2006) 0.83
An integrated analysis of molecular aberrations in NCI-60 cell lines. BMC Bioinformatics (2010) 0.81
Use of gene expression and pathway signatures to characterize the complexity of human melanoma. Am J Pathol (2011) 0.81
Molecular bases of cutaneous and uveal melanomas. Patholog Res Int (2011) 0.81
Gene network analyses point to the importance of human tissue kallikreins in melanoma progression. BMC Med Genomics (2011) 0.81
Genomic signatures for individualized treatment of malignant tumors. Curr Drug Discov Technol (2008) 0.80
Predictive pathology of cytostatic drug resistance and new anti-cancer targets. Recent Results Cancer Res (2007) 0.80
Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma? J Skin Cancer (2011) 0.76
Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol (2005) 5.11
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol (2008) 2.76
Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res (2008) 2.61
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
PR-Set7-dependent lysine methylation ensures genome replication and stability through S phase. J Cell Biol (2007) 2.39
Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study. Am J Clin Nutr (2013) 2.20
An essential function for NBS1 in the prevention of ataxia and cerebellar defects. Nat Med (2005) 2.06
Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell (2002) 2.05
The composition of surrogate alcohols consumed in Russia. Alcohol Clin Exp Res (2005) 1.88
Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One (2010) 1.84
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res (2009) 1.84
Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett (2011) 1.62
Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol Cell Biol (2004) 1.61
Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell Metab (2006) 1.57
Illegally produced alcohol. BMJ (2012) 1.50
Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res (2003) 1.45
Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev (2012) 1.38
Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double-strand breaks. EMBO J (2006) 1.36
Histone acetylation and chromatin signature in stem cell identity and cancer. Mutat Res (2007) 1.31
Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol (2010) 1.26
Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood (2006) 1.24
Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays (2010) 1.21
DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J (2012) 1.21
The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis (2005) 1.21
MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics (2013) 1.21
Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. PLoS One (2013) 1.17
Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest (2004) 1.17
An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet (2004) 1.16
Epigenetic drivers and genetic passengers on the road to cancer. Mutat Res (2008) 1.16
Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol Endocrinol (2010) 1.15
HoxA3 is an apical regulator of haemogenic endothelium. Nat Cell Biol (2010) 1.13
Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res (2010) 1.13
Mammalian Ino80 mediates double-strand break repair through its role in DNA end strand resection. Mol Cell Biol (2011) 1.10
Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma. Mod Pathol (2009) 1.09
Parthenolide: from plant shoots to cancer roots. Drug Discov Today (2013) 1.09
Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk. Environ Mol Mutagen (2013) 1.08
Histone modifications and cancer. Adv Genet (2010) 1.08
Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol Cell Biol (2004) 1.03
Microarray analysis of gene expression in rat hippocampus after chronic ethanol treatment. Neurochem Res (2002) 1.03
DNA methylation and cancer: ghosts and angels above the genes. Curr Opin Oncol (2011) 1.03
The transcriptional histone acetyltransferase cofactor TRRAP associates with the MRN repair complex and plays a role in DNA double-strand break repair. Mol Cell Biol (2006) 1.01
Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. Epigenetics (2009) 1.00
Reference genes for quantitative real time PCR in UVB irradiated keratinocytes. J Photochem Photobiol B (2008) 0.99
Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics (2011) 0.97
Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids. Methods (2010) 0.97
DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract. Epigenetics (2012) 0.97
Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Epigenetics (2011) 0.97
DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection. J Infect Dis (2010) 0.96
Mouse striatal transcriptome analysis: effects of oral self-administration of alcohol. Alcohol (2004) 0.96
SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells. Blood (2005) 0.95
HAT cofactor Trrap regulates the mitotic checkpoint by modulation of Mad1 and Mad2 expression. EMBO J (2004) 0.93
Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci U S A (2013) 0.93
From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med (2012) 0.93
Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis. Carcinogenesis (2010) 0.92
Epigenetic information in chromatin: the code of entry for DNA repair. Cell Cycle (2006) 0.92
EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int J Cancer (2007) 0.92
DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study. Epigenetics (2011) 0.92
Deciphering the epigenetic code: an overview of DNA methylation analysis methods. Antioxid Redox Signal (2013) 0.91
Chromatin structure in double strand break repair. DNA Repair (Amst) (2013) 0.90
Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers. Int J Cancer (2011) 0.90
Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome. Epigenetics (2012) 0.90
Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. J Leukoc Biol (2008) 0.89
Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet Cytogenet (2008) 0.89
Epigenetic Signatures of Cigarette Smoking. Circ Cardiovasc Genet (2016) 0.88
Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages. Thromb Haemost (2010) 0.88
CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression. Carcinogenesis (2011) 0.88
Shaping chromatin for repair. Mutat Res (2012) 0.88
Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. Otol Neurotol (2009) 0.87
Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007. Mol Oncol (2008) 0.87
Optimized DNA extraction from neonatal dried blood spots: application in methylome profiling. BMC Biotechnol (2014) 0.87
DNA demethylating agents and epigenetic therapy of cancer. Adv Genet (2010) 0.86
Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients. Liver Int (2004) 0.86
Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumour Biol (2012) 0.86
Epigenetic signatures in cancer: Implications for the control of cancer in the clinic. Curr Opin Mol Ther (2010) 0.86
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage. Eur J Clin Pharmacol (2004) 0.86
HAT cofactor TRRAP mediates beta-catenin ubiquitination on the chromatin and the regulation of the canonical Wnt pathway. Cell Cycle (2008) 0.85
Variants of kappa-opioid receptor gene and mRNA in alcohol-preferring and alcohol-avoiding mice. Alcohol (2003) 0.85
Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function. Respiration (2011) 0.85
Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles. Genes Chromosomes Cancer (2010) 0.84
Methylome analysis and epigenetic changes associated with menarcheal age. PLoS One (2013) 0.84
Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α. PLoS Pathog (2013) 0.83
Challenges and opportunities in research on early-life events/exposures and cancer development later in life. Cancer Causes Control (2012) 0.83
Transcriptional regulation of the human tumor suppressor DOK1 by E2F1. Mol Cell Biol (2012) 0.83
Histone acetyltransferase cofactor Trrap maintains self-renewal and restricts differentiation of embryonic stem cells. Stem Cells (2013) 0.83
Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease. Nephron Clin Pract (2009) 0.83
Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. Neurochem Res (2007) 0.82
Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch. BMC Genomics (2014) 0.82
Histone acetyltransferase cofactor Trrap is essential for maintaining the hematopoietic stem/progenitor cell pool. J Immunol (2009) 0.82
The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Tumour Biol (2012) 0.81
Methylation patterns in sentinel genes in peripheral blood cells of heavy smokers: Influence of cruciferous vegetables in an intervention study. Epigenetics (2011) 0.81
Glutamate receptor metabotropic 7 is cis-regulated in the mouse brain and modulates alcohol drinking. Genomics (2007) 0.81
Epigenetic signatures in stem cells and cancer stem cells. Epigenomics (2009) 0.81